Recent Articles
Medicare versus Medicaid: Key differences
Lost a tooth? What to know about dental implants
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims
Gatorade. Liquid IV. Do you need extra electrolytes?
Sexual violence can cast a long shadow on health
Prostate cancer: Short-course radiation just as effective as longer-term treatments
Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet
Can a quick snooze help with energy and focus? The science behind power naps
Autism: The challenges and opportunities of an adult diagnosis
Hospice care: Overview of a compassionate approach to end-of-life care
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Men's Health
Promising therapy if PSA rises after prostate cancer surgery
Men's Health
An emerging treatment option for men on active surveillance
Men's Health
Some men whose prostate cancer progresses can safely delay treatment
Men's Health
New treatment approved for late-stage prostate cancer
Men's Health
Comparing traditional and robotic-assisted surgery for prostate cancer
Men's Health
Treatment with abiraterone significantly improves survival in advanced prostate cancer
Men's Health
New study investigates treatment-associated regrets in prostate cancer
Men's Health
Acupuncture relieves prostatitis symptoms in study
Men's Health
Recent study shows more complications with alternative prostate biopsy method
Men's Health
Study: No effect on cognitive functioning from treatments for advanced prostate cancer
Men's Health
Cardiovascular safety from prostate cancer drugs remains uncertain
Men's Health
Level of health literacy affects treatment choice for slow-growing prostate cancer
Men's Health
A new treatment for advanced prostate cancer improves survival in phase 3 clinical trial
Men's Health
Large review study finds low risk of erectile dysfunction after prostate biopsy
Men's Health
American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer
Charlie Schmidt
An emerging treatment option for men with recurring prostate cancer after radiation therapy
Charlie Schmidt
Improving PET scans are good news for doctors and patients alike
Charlie Schmidt
Hormonal therapies for advanced prostate cancer linked to a higher risk of falls and fractures
Charlie Schmidt
New high-resolution imaging scans approved for use in prostate cancer
Charlie Schmidt
The sequence of hormonal therapy and radiation affects outcomes in men treated for prostate cancer
Charlie Schmidt
New online model identifies which men can have fewer biopsies on active surveillance
Charlie Schmidt
Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms
Charlie Schmidt
Hormonal treatments for prostate cancer are often given late
Charlie Schmidt
A new hormonal therapy for prostate cancer is under expedited FDA review
Recent Articles
Medicare versus Medicaid: Key differences
Lost a tooth? What to know about dental implants
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims
Gatorade. Liquid IV. Do you need extra electrolytes?
Sexual violence can cast a long shadow on health
Prostate cancer: Short-course radiation just as effective as longer-term treatments
Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet
Can a quick snooze help with energy and focus? The science behind power naps
Autism: The challenges and opportunities of an adult diagnosis
Hospice care: Overview of a compassionate approach to end-of-life care
